American Trust’s Pfizer PFE Stock Holding History

American Trust’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-14,788	Closed	-$603K	–	462
2023 Q1	$603K	Buy	14,788 +548	+4%	+$23.7K	0.04%	187
2022 Q4	$730K	Buy	14,240 +2,036	+17%	+$97.6K	0.07%	159
2022 Q3	$534K	Sell	12,204 -429	-3%	-$20.8K	0.05%	184
2022 Q2	$663K	Buy	+12,633	New	+$644K	0.05%	171

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

American Trust's PFE Position: Q2 2023 in Review

American Trust sold out of Pfizer (PFE) in Q2 2023, closing a stake of 14,788 shares — an estimated $603K sold.

American Trust first reported a position in PFE in Q2 2022 and held it in 4 quarters. The position peaked at $730K in Q4 2022. 3,042 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

American Trust reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
American Trust sold 14,788 Pfizer shares in Q2 2023, an estimated $603K.
American Trust first reported a position in Pfizer in Q2 2022 and held it in 4 quarters.
American Trust's Pfizer position peaked at $730K in Q4 2022.
3,042 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on American Trust's 13F filing for Q2 2023, filed 14 Aug 2023.